Brief: Biocept Inc Says Lowering Headcount By More Than 40% From Our Pre-Covid-19 Testing Level

Biocept

17/04/2023 21:51

April 17 (Reuters) - Biocept Inc  BIOC.O :
    * BIOCEPT REPORTS 2022 FINANCIAL RESULTS
    * BIOCEPT INC- LOWERING HEADCOUNT BY MORE THAN 40% FROM OUR
PRE-COVID-19 TESTING LEVEL
    * BIOCEPT INC- IMPLEMENTED COST-EFFICIENCY MEASURES SUCH AS
ENHANCING LABORATORY OPERATIONS, REDUCING SERVICES FROM OUTSIDE
VENDORS
    * BIOCEPT INC- HAVE STARTED COST EFFICIENCY MEASURES PROCESS
AND
EXPECT FULL IMPLEMENTATION OVER NEXT FEW MONTHS

Source text for Eikon:  ID:nBw21cHM6a 
Further company coverage:  BIOC.O 

 ((Reuters.Briefs@thomsonreuters.com;))